18 May 2022 | BST (UTC+1)

Thierry Guillaudeux

Senior Vice President, Immuno-Oncology
Kineta, Inc.
Thierry Guillaudeux
Executive Vice President R&D at Kineta Inc. a clinical stage biotech company developing anti-tumor therapeutic antibodies against Innate immune targets. I am lead the entire R&D team and i am a member of the executive team including the CEO, the President and the General counsel. Former University Professor at University of Rennes in France were i was the director of a research institute. I have more than 30 years experience in Immuno-oncology. I have a strong experience in management and leadership.


No data was found

Other Speakers

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Download Brochure

Full details regarding the Immuno Series UK are available for download in the Conference Brochure